Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MeiraGTxRubius TherapeuticsGENFIT S A/ADROyster Point PharmaOsiris Therapeutics
SymbolNASDAQ:MGTXNASDAQ:RUBYNASDAQ:GNFTNASDAQ:OYSTOTCMKTS:OSIR
Price Information
Current Price$11.83$4.35$16.40$30.70$18.99
52 Week RangeBuyHoldBuyBuyN/A
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyN/A
Consensus Price Target$38.33$10.00$51.25$46.25N/A
% Upside from Price Target224.03% upside129.89% upside212.50% upside50.65% upsideN/A
Trade Information
Market Cap$434.08 million$341.37 million$576.95 million$662.38 million$655.69 million
Beta1.972.12N/AN/AN/A
Average Volume151,761765,79035,35269,959202,293
Sales & Book Value
Annual Revenue$13.29 millionN/A$8.85 millionN/AN/A
Price / Sales32.78N/A70.10N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.22 per share$3.44 per shareN/A$6.43 per shareN/A
Price / Book2.27N/A∞N/AN/A
Profitability
Net Income$-54,750,000.00$-163,460,000.00$-93,910,000.00$-45,710,000.00N/A
EPS($1.65)($2.08)N/A($9.97)N/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E RatioN/AN/AN/AN/A∞
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-411.84%N/AN/AN/AN/A
Return on Equity (ROE)-33.20%-50.42%N/AN/AN/A
Return on Assets (ROA)-19.00%-38.31%N/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.11%0.32%N/AN/AN/A
Current Ratio5.47%8.57%N/A26.33%N/A
Quick Ratio5.47%8.57%N/A26.33%N/A
Ownership Information
Institutional Ownership Percentage45.28%N/A2.82%63.52%0.28%
Insider Ownership Percentage17.40%58.40%N/AN/A43.40%
Miscellaneous
Employees6814214818N/A
Shares Outstanding36.82 million80.32 million37.83 million21.37 million34.53 million
Next Earnings Date5/12/2020 (Estimated)5/20/2020 (Estimated)N/A5/28/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel